206 related articles for article (PubMed ID: 15944517)
1. Metabolic abnormalities and the medical management of calcium oxalate nephrolithiasis.
Chandhoke PS
Minerva Urol Nefrol; 2005 Mar; 57(1):9-16. PubMed ID: 15944517
[TBL] [Abstract][Full Text] [Related]
2. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
[TBL] [Abstract][Full Text] [Related]
3. Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis.
Porile JL; Asplin JR; Parks JH; Nakagawa Y; Coe FL
J Am Soc Nephrol; 1996 Apr; 7(4):602-7. PubMed ID: 8724894
[TBL] [Abstract][Full Text] [Related]
4. Animal models of kidney stone formation: an analysis.
Khan SR
World J Urol; 1997; 15(4):236-43. PubMed ID: 9280052
[TBL] [Abstract][Full Text] [Related]
5. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
6. [Metabolic disorders and kidney stone].
Nihon Jinzo Gakkai Shi; 1986 Jul; 28(7):995-1007. PubMed ID: 3795610
[No Abstract] [Full Text] [Related]
7. Correlation between sKL and Nrf2 plasma levels and calcium oxalate urolithiasis.
Aihemaitijiang B; Ruotian L; Qi Y; Mahemuti M
Int Urol Nephrol; 2023 Jul; 55(7):1671-1676. PubMed ID: 37198517
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology and management of calcium stones.
Park S; Pearle MS
Urol Clin North Am; 2007 Aug; 34(3):323-34. PubMed ID: 17678983
[TBL] [Abstract][Full Text] [Related]
9. Electron paramagnetic resonance study of iron oxalate in calcium oxalate renal stones.
Shields H; Sane D; Resnick MI
Invest Urol; 1979 May; 16(6):428-31. PubMed ID: 221436
[TBL] [Abstract][Full Text] [Related]
10. Nephrolithiasis and intestinal disease.
Dobbins JW
J Clin Gastroenterol; 1985 Feb; 7(1):21-4. PubMed ID: 3980960
[TBL] [Abstract][Full Text] [Related]
11. Throw no stones: how to prevent calcium oxalate renal stones.
Eichner ER
Curr Sports Med Rep; 2010; 9(5):260-1. PubMed ID: 20827088
[No Abstract] [Full Text] [Related]
12. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.
Nakagawa Y; Ahmed M; Hall SL; Deganello S; Coe FL
J Clin Invest; 1987 Jun; 79(6):1782-7. PubMed ID: 3584470
[TBL] [Abstract][Full Text] [Related]
13. Calcium oxalate nephrolithiasis: defective oxalate transport.
Borsatti A
Kidney Int; 1991 Jun; 39(6):1283-98. PubMed ID: 1895680
[No Abstract] [Full Text] [Related]
14. Medical therapy, calcium oxalate urolithiasis.
Ruml LA; Pearle MS; Pak CY
Urol Clin North Am; 1997 Feb; 24(1):117-33. PubMed ID: 9048856
[TBL] [Abstract][Full Text] [Related]
15. [Prediction of changes in chemical form of urolithiasis].
Konstantinova OV; Ianenko ÉK
Urologiia; 2011; (2):19-23. PubMed ID: 21815453
[TBL] [Abstract][Full Text] [Related]
16. Perturbations of the Gut Microbiome and Metabolome in Children with Calcium Oxalate Kidney Stone Disease.
Denburg MR; Koepsell K; Lee JJ; Gerber J; Bittinger K; Tasian GE
J Am Soc Nephrol; 2020 Jun; 31(6):1358-1369. PubMed ID: 32381601
[TBL] [Abstract][Full Text] [Related]
17. The relationship between gut microbiota and short chain fatty acids in the renal calcium oxalate stones disease.
Liu Y; Jin X; Hong HG; Xiang L; Jiang Q; Ma Y; Chen Z; Cheng L; Jian Z; Wei Z; Ai J; Qi S; Sun Q; Li H; Li Y; Wang K
FASEB J; 2020 Aug; 34(8):11200-11214. PubMed ID: 32645241
[TBL] [Abstract][Full Text] [Related]
18. Epidemiologic evidence for the role of oxalate in idiopathic nephrolithiasis.
Curhan GC
J Endourol; 1999 Nov; 13(9):629-31. PubMed ID: 10608513
[TBL] [Abstract][Full Text] [Related]
19. Calcium oxalate renal stones.
Prien EL
Annu Rev Med; 1975; 26():173-9. PubMed ID: 1096755
[No Abstract] [Full Text] [Related]
20. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
Khan SR; Thamilselvan S
Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
